1.
Shinde S, Avhad S, Morkar V, Patki C, Chikhale H, Borse L. Overview on remogliflozin SGLT-2 inhibitor in the management of type-2 diabetic mellitus in human beings. FEB [Internet]. 2023 Dec. 28 [cited 2025 Dec. 6];112(4):156-67. Available from: https://feb.buketov.edu.kz/bmg-vestnik/article/view/34